QTREX Quantum Ltd. (QTEX)
NASDAQ: QTEX · Real-Time Price · USD
1.610
-0.030 (-1.83%)
At close: Jun 26, 2026, 4:00 PM EDT
1.570
-0.040 (-2.48%)
After-hours: Jun 26, 2026, 7:57 PM EDT
Company Description
QTREX Quantum Ltd., a specialty medical device company, engages in the research, development, manufacturing, and marketing of proprietary life support technologies for the treatment of acute respiratory failure in Israel.
It offers INSPIRA ART100, a life support system used in procedures requiring cardiopulmonary bypass for six hours or less.
It also offers HYLA blood sensor, which is designed to perform real-time sampling and analysis of key blood parameter measurements.
The company was formerly known as Inspira Technologies Oxy B.H.N. Ltd. and changed its name to QTREX Quantum Ltd. in May 2026.
QTREX Quantum Ltd. was incorporated in 2018 and is headquartered in Ra'anana, Israel.
QTREX Quantum Ltd.
| Country | Israel |
| Founded | 2018 |
| IPO Date | Jul 14, 2021 |
| Industry | Computer Hardware |
| Sector | Technology |
| Employees | 37 |
| CEO | Dagi Ben-Noon |
Contact Details
Address: 2 Ha-Tidhar St. Ra'anana, 4366504 Israel | |
| Phone | 972 4 623 0333 |
| Website | q-trex.com |
Stock Details
| Ticker Symbol | QTEX |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001837493 |
| ISIN Number | IL0011715781 |
| SIC Code | 3841 |
Key Executives
| Name | Position |
|---|---|
| Dagi Shahar Ben-Noon | Co-Founder, Chief Executive Officer and Director |
| Yafit Tehila | Chief Financial Officer |
| Avi Shabtai | Chief Operating Officer and Vice President of Research and Development |
| Daniella Yeheskely-Hayon M.B.A., Ph.D. | Chief Technology Officer |
| Sivan Ozeri | Administrative Manager |
| Adi Shmueli | Director of Marketing |
| Mike Hershkovitz | Vice President of Global Sales |
| Yoav Rozanovich | Chief Business Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Jun 18, 2026 | EFFECT | Notice of Effectiveness |
| Jun 18, 2026 | 6-K | Report of foreign issuer |
| Jun 16, 2026 | EFFECT | Notice of Effectiveness |
| Jun 16, 2026 | POS AM | Post-Effective amendments for registration statement |
| Jun 11, 2026 | 6-K | Report of foreign issuer |
| Jun 9, 2026 | 6-K | Report of foreign issuer |
| Jun 4, 2026 | F-3 | Filing |
| Jun 1, 2026 | 6-K | Report of foreign issuer |
| Jun 1, 2026 | 6-K | Report of foreign issuer |
| Jun 1, 2026 | 144 | Filing |